Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

Dr. Joshua Logan, DC, BCN, founder of True North Health Center, is board-certified in neuropathy and has been awarded “Best Holistic Pain Management” in Colorado Springs. The ...

- The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

Arialief is a nutritional supplement skillfully produced to target the root cause of sciatic nerve discomfort. It comb ...

Patients with cervical cancer demonstrated better sexual health and quality of life after undergoing simple hysterectomies ...

The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...

A team of international researchers, including scientists from the University of Adelaide, has developed a new approach to pain relief using a well-known chemical reaction. This new method, which ...

Peripheral neuropathy encompasses a variety of conditions marked by damage or lesions to peripheral nerves, resulting in symptoms such as pain, itch, and sensory disturbances. Diseases such as ...

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

In August, Trevena underwent a reverse stock split, a move often enacted when a company’s share price dips too low. The split wasn’t enough to stave off delisting, with Nasdaq removing Trevena’s stock ...